Skip to main content
GKB logo

GKB — Investor Relations & Filings

Ticker · 1707 ISIN · TW0001707008 TW Manufacturing
Open in API
Filings indexed 2,129 across all filing types
Latest filing 2022-08-10 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1707

About GKB

http://www.grapeking.com.tw

Grape King Bio Ltd. is a biotechnology firm specializing in the research, development, and production of health supplements and functional beverages. Established in 1969, the company has evolved into a prominent provider of probiotics, energy drinks, and nutritional products tailored for diverse age groups. It operates a dedicated Biotech Research Institute staffed by over 160 specialists, focusing on proprietary fermentation technology and innovative formulations that have garnered over 170 international awards. The company offers a comprehensive one-stop OEM/ODM platform, providing integrated manufacturing services across various dosage forms. Guided by the philosophy of "Technology, Health, and Hope," Grape King Bio serves global markets through its own brands and strategic subsidiaries, emphasizing high-quality standards and advanced biotechnological applications to enhance consumer well-being.

Recent filings

Filing Released Lang Actions
111年7月營業收入
Interim / Quarterly Report Classification · 85% confidence The document is a summarized revenue report for a company named 葡萄王 for the month and year-to-date period ending July 2022 (民國111年07月). It contains numerical financial data such as monthly and cumulative net operating revenue, comparisons to prior year periods, and percentage changes. The document is short (774 characters) and appears to be a periodic financial summary rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). It also does not fit other categories like Earnings Release (ER) which usually highlight key financial results in a narrative form. Given the nature of the data and the format, this document best fits the category of Interim / Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. Q2 2022
2022-08-10 Chinese
公告本公司董事會決議通過111年第二季合併財務報告
Interim / Quarterly Report Classification · 95% confidence The document is a public announcement from a listed company (1707 葡萄王) reporting the board of directors' approval of the consolidated financial report for the second quarter of the year 111 (Taiwan calendar, equivalent to 2022). It includes detailed financial figures for the period from January 1 to June 30, such as revenue, gross profit, operating profit, net profit, earnings per share, total assets, liabilities, and equity. The document is 921 characters long, which is relatively short but contains substantive financial data and analysis for a half-year period. This matches the definition of an Interim / Quarterly Report (IR), which requires actual financial statements or substantive financial data for a period shorter than a full fiscal year. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2022
2022-08-10 Chinese
111年07月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings of company insiders, including directors, managers, and their related parties. It shows changes in shareholdings, types of shares held, and other related data. The content is focused on insider share transactions and holdings rather than financial results, management changes, or other corporate events. There is no indication of it being a full financial report, earnings release, or regulatory announcement about voting or dividends. The document is a report of personal share transactions by company directors and executives, which matches the definition of Director's Dealing (DIRS). The document length is sufficient and contains substantive data, not just an announcement or certification.
2022-08-09 Chinese
111年07月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by company insiders, including directors and senior management, showing their current holdings, pledged shares, and related information. It lists individual names, titles, and share counts, which is characteristic of insider share transactions or holdings disclosures. There is no indication of financial results, management discussion, or report publication. The document is not a report itself but a disclosure of insider shareholdings. This fits the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives. The document length is 2676 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report. Therefore, the classification is DIRS with high confidence.
2022-08-09 Chinese
111年6月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a financial disclosure from a listed company (葡萄王) providing information about fund loans and endorsement guarantees for the current and previous month, with amounts all zero. It is a regulatory disclosure of financial status related to guarantees and loans, typical of a regulatory filing rather than a full financial report or announcement. The document is short (602 characters) and contains tabular data on financial guarantees but no comprehensive financial statements or management discussion. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS) as it is a routine compliance disclosure without detailed financial analysis or report publication.
2022-07-06 Chinese
111年6月營業收入
Regulatory Filings Classification · 85% confidence The document is a summarized revenue report for a company named 葡萄王 for the period ending June 2022 (民國111年06月). It contains monthly and year-to-date net operating revenue figures with comparisons to the previous year. The content is brief (772 characters) and focuses on financial data for a short period, but it does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). It also does not appear to be an announcement or notice about a report publication, nor is it a regulatory filing or certification. Given the nature of the data (monthly revenue summary) and the lack of detailed financial statements, the best fit is a Regulatory Filing (RNS) as a general financial disclosure that does not meet the threshold for a full interim report or annual report.
2022-07-06 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.